CEVEC Pharmaceuticals GmbH

📍 Köln, Germany🗓 Founded 2003👥 33 employees💰 Last funded Apr 2017
CEVEC is a leading provider of high-performance cell technology for the manufacturing of advanced bio-therapeutics from R&D to manufacturing scale. The company’s product portfolio comprises platform technologies for gene therapy viral vectors (AAV, Adenoviral vectors, Lentiviral vectors,), vaccines and complex recombinant proteins. With the ELEVECTA® Technology, CEVEC offers a unique solution for large-scale production of AAV vectors using producer cell lines with all necessary components stably integrated into the cell. The technology is based on suspension cells and does not require any expensive transfection reagents and cGMP plasmids. CEVEC’s CAP® Technology based on human suspension cells is the ideal production platform for RCA-free Adenoviral vectors, Lentiviral vectors, Oncolytic viruses, Viral vaccines and exosomes. With the CAP-Go® Technology CEVEC provides a solution to the increasing need for recombinant production of complex and highly glycosylated protein molecules, including laminins, coagulation factors and plasma proteins.
4
Total investors
0
Early stage
0
Mid stage
2
Late stage
2003
Founded
Investor geography2 countries
Germany
3
United Kingdom
1
Investor activity2009–2017 · investors recorded per year
200922016120171
Recent (last 2y)Earlier
Frequently asked questions
Who invested in CEVEC Pharmaceuticals GmbH?
CEVEC Pharmaceuticals GmbH has 4 investors on record on gritt.io and 2 late-stage investors.
When did CEVEC Pharmaceuticals GmbH last raise funding?
The most recent investment in CEVEC Pharmaceuticals GmbH recorded on gritt.io was in April 2017.
When was CEVEC Pharmaceuticals GmbH founded?
CEVEC Pharmaceuticals GmbH was founded in 2003.
What industry is CEVEC Pharmaceuticals GmbH in?
CEVEC Pharmaceuticals GmbH operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is CEVEC Pharmaceuticals GmbH based?
CEVEC Pharmaceuticals GmbH is headquartered in Köln, Germany.